Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-000837
Filing Date
2025-06-09
Accepted
2025-06-09 16:06:41
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 e664606_4-whaley.html 4  
1 FORM 4 e664606_4-whaley.xml 4 4000
  Complete submission text file 0001193805-25-000837.txt   5589
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERNIX THERAPEUTICS HOLDINGS, INC. 10 NORTH PARK PLACE, SUITE 201 MORRISTOWN NJ 07960
Business Address
Whaley Glenn (Reporting) CIK: 0001724623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 251034083